1. Talib, M., Dagnelie, G. & Boon, C. J. F. Recording and Analysis of Goldmann Kinetic Visual Fields. Methods Mol. Biol. 1715, 327–338 (2018). pdf
  2. Bittner, A. K. et al. Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa. Acta Ophthalmol. 1–11 (2017). doi:10.1111/aos.13581. pdf
  3. Dagnelie, G. et al. Performance of real-world functional vision tasks by blind subjects improves after implantation with the Argus® II retinal prosthesis system. Clin. Exp. Ophthalmol. 45, 152–159 (2017). pdf
  4. Dagnelie, G., Jeter, P. E. & Adeyemo, O. Optimizing the ULV-VFQ for Clinical Use Through Item Set Reduction: Psychometric Properties and Trade-Offs. Transl. Vis. Sci. Technol. 6, 12 (2017). pdf
  5. Adeyemo, O. et al. Living with Ultra-Low Vision: An Inventory of Self-Reported Visually Guided Activities by Individuals with Profound Visual Impairment. Transl. Vis. Sci. Technol. 6, 10 (2017). pdf
  6. Duncan, J. L. et al. Improvements in vision-related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis. Clin. Exp. Optom. 100, 144–150 (2017). pdf
  7. Talib, M. et al. Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study. Ophthalmology 124, 884–895 (2017). pdf
  8. Biswas, P. et al. Genetic analysis of 10 pedigrees with inherited retinal degeneration by exome sequencing and phenotype-genotype association. Physiol. Genomics 49, 216–229 (2017). pdf
  9. Jeter, P. E., Rozanski, C., Massof, R., Adeyemo, O. & Dagnelie, G. Development of the Ultra-Low Vision Visual Functioning Questionnaire (ULV-VFQ). Transl. Vis. Sci. Technol. 6, 11 (2017). pdf
  10. Ghodasra, D. H. et al. Worldwide Argus II implantation: Recommendations to optimize patient outcomes. BMC Ophthalmol. 16, 1–8 (2016). pdf
  11. Pierrache, L. H. M. et al. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. Ophthalmology 123, 1151–1160 (2016). pdf
  12. Barry, M. P. et al. Variability and Errors of Manually Digitized Goldmann Visual Fields. Optom. Vis. Sci. 28, 1304–1314 (2016). pdf
  13. Humayun, M. S., de Juan, E. & Dagnelie, G. The Bionic Eye: A Quarter Century of Retinal Prosthesis Research and Development. Ophthalmology 123, S89–S97 (2016). pdf
  14. Ho, A. C. et al. Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology 122, 1547–1554 (2016). pdf
  15. Long, M. et al. Intra-session test-retest reliability of magnitude and structure of center of pressure from the Nintendo Wii Balance BoardTM for a visually impaired and normally sighted population. Gait Posture 8, 444–454 (2016). pdf
  16. Barry, M. P. & Dagnelie, G. Hand-Camera Coordination Varies over Time in Users of the Argus® II Retinal Prosthesis System. Front. Syst. Neurosci. 10, 1–7 (2016). pdf
  17. Flax, M. et al. FLORATM: Phase I development of a functional vision assessment for prosthetic vision user. Clin. Exp. Ophthalmol.106, 201–207 (2016). pdf
  18. da Cruz, L. et al. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology 123, 2248–2254 (2016). pdf
  19. Stronks, H. C., Barry, M. P. & Dagnelie, G. Electrically evoked electroretinograms and pupil responses in Argus II retinal implant wearers. Doc. Ophthalmol. 132, 1–15 (2016). pdf
  20. Geruschat, D. R. et al. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years. Clin. Exp. Optom. 99, 227–232 (2016). pdf
  21. Stronks, C. H. & Dagnelie, G. The functional performance of the Argus II retinal prosthesis. Expert Rev. Med. Devices 27, 320–331 (2015). pdf
  22. Scholl, H. P. N. et al. Safety and proof-of-concept study of oral QLT091001 in retinitis pigmentosa due to inherited deficiencies of retinal pigment epithelial 65 protein (RPE65) or lecithin: Retinol acyltransferase (LRAT). PLoS One 10, 1–16 (2015). pdf
  23. Bittner, A. K., Rosenfarb, A., Gould, J. M., Lac, M. & Dagnelie, G. Response to Re: A pilot study of an acupuncture protocol to improve visual function in retinitis pigmentosa patients. Clin. Exp. Ophthalmol. 4, 139–148 (2015). pdf
  24. Jeter, P. E., Moonaz, S. H., Bittner, A. K. & Dagnelie, G. Ashtanga-based yoga therapy increases the sensory contribution to postural stability in visually-impaired persons at risk for falls as measured by the Wii Balance Board: A pilot randomized controlled trial. PLoS One 10, 1–23 (2015). pdf
  25. Rozanski, C., Haythornthwaite, J. A., Dagnelie, G. & Bittner, A. K. Applying Theories and Interventions from Behavioral Medicine to Understand and Reduce Visual Field Variability in Patients with Vision Loss. Med Hypotheses 49, 1841–1850 (2015). pdf
  26. Dorn, J. D. et al. The Detection of Motion by Blind Subjects With the Epiretinal 60- Electrode (Argus II) Retinal Prosthesis. JAMA Ophthalmol 49, 1841–1850 (2014). pdf
  27. Manuscript, A., Blood, W. & Count, C. Orientation and Mobility Assessment in Retinal Prosthetic Clinical Trials. Optom. Vis. Sci. 49,1841–1850 (2014). pdf
  28. Koenekoop, R. K. et al. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: An open-label phase 1b trial. Lancet 384, 1513–1520 (2014). pdf
  29. Chung, S. T. L. et al. New Challenges in Low-Vision Research (Guest Editorial). Optom. Vis. Sci. 49, 1841–1850 (2014). pdf
  30. Bittner, A. K. et al. Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial. J Clin Exp Ophtalmol 5, 1–18 (2014). pdf
  31. Jeter, P. E., Nkodo, A.-F., Moonaz, S. H. & Dagnelie, G. A Systematic Review of Yoga for Balance in a Healthy Population. J. Altern. Complement. Med. 20, 221–232 (2014). pdf
  32. Bittner, A. K., Gould, J. M., Rosenfarb, A., Rozanski, C. & Dagnelie, G. A pilot study of an acupuncture protocol to improve visual function in retinitis pigmentosa patients. Clin. Exp. Optom. 97, 240–247 (2014). pdf
  33. Bittner, A. K., Jennifer A Haythornthwaite, Diener-West, M. & Dagnelie, G. Worse-than-usual visual fields measured in retinitis pigmentosa related to episodically decreased general health. Br. J. Ophthalmol. 97, 145–148 (2013). pdf
  34. Da Cruz, L. et al. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br. J. Ophthalmol. 97, 632–636 (2013). pdf
  35. Humayun, M. S., Dorn, J. D., Cruz, L., Dagnelie, G. & Sahel, J. Interim Results from the International Trial of Second Sight’s Visual Prosthesis. Ophthalmology 119, 779–788 (2013). pdf
  36. Christiaan Stronks, H., Barry, M. P. & Dagnelie, G. Electrically elicited visual evoked potentials in argus II retinal implant wearers. Investig. Ophthalmol. Vis. Sci. 54, 3891–3901 (2013). pdf
  37. Humayun, M. S. et al. Visual Perception Elicited by Electrical Stimulation
  38. of Retina in Blind Humans. Ophthalmology (2013). pdf
  39. Dagnelie, G. Age-related psychophysical changes and low vision. Investig. Ophthalmol. Vis. Sci. 54, 88–93 (2013). pdf
  40. Barry, M. P. & Dagnelie, G. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. Investig. Ophthalmol. Vis. Sci. 53, 5095–5101 (2012). pdf
  41. Dagnelie, G. Retinal implants: Emergence of a multidisciplinary field. Curr. Opin. Neurol. 25, 67–75 (2012). pdf
  42. Bittner, A. K., Haythornthwaite, J. A., Diener-West, M. & Dagnelie, G. Photopsias are related in part to perceived stress and positive mood in retinitis pigmentosa. Eye 26, 101–108 (2012). pdf
  43. Bittner, A. K., Ibrahim, M. A., Haythornthwaite, J. A., Diener-West, M. & Dagnelie, G. Vision test variability in retinitis pigmentosa and psychosocial factors. Optom. Vis. Sci. 88, 1496–1506 (2011). pdf
  44. Bittner, A. K., Iftikhar, M. H. & Dagnelie, G. Test-Retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa. Investig. Ophthalmol. Vis. Sci. 52, 8042–8046 (2011). pdf
  45. Eng, J. G. et al. Morphometric analysis of optic nerves and retina from an end-stage retinitis pigmentosa patient with an implanted active epiretinal array. Investig. Ophthalmol. Vis. Sci. 52, 4610–4616 (2011). pdf
  46. Bittner, A. K., Jeter, P. & Dagnelie, G. Grating acuity and contrast tests for clinical trials of severe vision loss. Optom. Vis. Sci. 88,1153–1163 (2011). pdf
  47. Bittner, A. K., Diener-West, M. & Dagnelie, G. Characteristics and possible visual consequences of photopsias as vision measures are reduced in retinitis pigmentosa. Investig. Ophthalmol. Vis. Sci. 52, 6370–6376 (2011). pdf
  48. Ahuja, A. K. et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br. J. Ophthalmol. 95, 539–543 (2011). pdf
  49. Wilker, S. C., Dagnelie, G. & Goldberg, M. F. Retinitis pigmentosa and punctate cataracts in mevalonic aciduria. Retin. Cases Br. Reports 4, 34–36 (2010). pdf
  50. Humayun, M. S. et al. Preliminary 6 month results from the argusTM II epiretinal prosthesis feasibility study. Proc. 31st Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. Eng. Futur. Biomed. EMBC 2009 4566–4568 (2009). doi:10.1109/IEMBS.2009.5332695. pdf
  51. Kubal, A., Dagnelie, G. & Goldberg, M. Ocular albinism with absent foveal pits but without nystagmus, photophobia, or severely reduced vision. J. AAPOS 13, 610–612 (2009). pdf
  52. Srivastava, N. R., Troyk, P. R. & Dagnelie, G. Detection, eye-hand coordination and virtual mobility performance in simulated vision for a cortical visual prosthesis device. J. Neural Eng. 6, (2009). pdf
  53. Rolkosky, D. J., Dagnelie, G., Kramer, K., Havey, G. & Seifert, G. J. Calibration tools for PC-based vision assessment. Proc. 31st Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. Eng. Futur. Biomed. EMBC 2009 781–784 (2009). doi:10.1109/IEMBS.2009.5333596. pdf
  54. Salgado, C. M., Dagnelie, G. & Miller, N. R. Bitemporal hemianopia caused by retinal disease. Arch Ophthalmol 127, 2007–2010 (2009). pdf
  55. Bittner, A. K., Diener-West, M. & Dagnelie, G. A survey of photopsias in self-reported retinitis pigmentosa: Location of photopsias is related to disease severity. Retina 29, 1513–1521 (2009). pdf
  56. Kiser, A. K., Deschler, E. K. & Dagnelie, G. Visual function and performance with blue-light blocking filters in age-related macular degeneration. Clin. Exp. Ophthalmol. 36, 514–520 (2008). pdf
  57. Wang, L., Yang, L. & Dagnelie, G. Virtual wayfinding using simulated prosthetic vision in gaze-locked viewing. Optom. Vis. Sci. 85,E1057–E1063 (2008). pdf
  58. Dagnelie, G. Psychophysical Evaluation for Visual Prosthesis. Annu. Rev. Biomed. Eng. 10, 339–368 (2008). pdf
  59. Adackapara, C. A., Sunness, J. S., Dibernardo, C. W., Melia, B. M. & Dagnelie, G. Prevalence of cystoid macular edema and stability in OCT retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina 28, 103–110 (2008). pdf
  60. Hallum, L. E., Dagnelie, G., Suaning, G. J. & Lovell, N. H. Simulating auditory and visual sensorineural prostheses: A comparative review. J. Neural Eng. 4, (2007). pdf
  61. Velikay-Parel, M. et al. Repeated mobility testing for later artificial visual function evaluation. J. Neural Eng. 4, (2007). pdf
  62. Dagnelie, G. et al. Real and virtual mobility performance in simulated prosthetic vision. J. Neural Eng. 4, (2007). pdf
  63. Dagnelie, G. Visual prosthetics 2006: Assessment and expectations. Expert Rev. Med. Devices 3, 315–325 (2006). pdf
  64. Hedin, D. S. et al. Thermal imaging aid for the blind. Annu. Int. Conf. IEEE Eng. Med. Biol. – Proc. 4131–4134 (2006). doi:10.1109/IEMBS.2006.259360. pdf
  65. Dagnelie, G. & Schuchard, R. A. The state of visual prosthetics — Hype or promise ? 44, 7–8 (2006). pdf
  66. Kiser, A. K., Mladenovich, D., Eshraghi, F., Bourdeau, D. & Dagnelie, G. Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease. Investig. Ophthalmol. Vis. Sci. 47, 444–452 (2006). pdf
  67. Dagnelie, G., Barnett, D., Humayun, M. S. & Thompson, R. W. Paragraph text reading using a pixelized prosthetic vision simulator: Parameter dependence and task learning in free-viewing conditions. Investig. Ophthalmol. Vis. Sci. 47, 1241–1250 (2006). pdf
  68. Bahrami, H., Melia, M. & Dagnelie, G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 6, 1–12 (2006). pdf
  69. Hayes, J. S. et al. Visually Guided Performance of Simple Tasks Using Simulated Prosthetic Vision. Artif. Organs 27, 1016–1028 (2003). pdf
  70. Humayun, M. S. et al. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res. 43, 2573–2581 (2003). pdf
  71. Thompson, R. W., Barnett, G. D., Humayun, M. S. & Dagnelie, G. Facial Recognition Using Simulated Prosthetic Pixelized Vision. Investig. Ophthalmol. Vis. Sci. 44, 5035–5042 (2003). pdf
  72. Semba, R. D. & Dagnelie, G. Are lutein and zeaxanthin conditionally essential nutrients for eye health? Med. Hypotheses 61, 465–472 (2003). pdf
  73. Margalit, E. et al. Retinal prosthesis for the blind. Surv. Ophthalmol. 47, 335–356 (2002). pdf
  74. Dagnelie, G., Zorge, I. & McDonald, T. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 71, 147–64 (2000). pdf
  75. Humayun, M. S. et al. Human neural retinal transplantation. Investig. Ophthalmol. Vis. Sci. 41, 3100–3106 (2000). pdf
  76. Weiland, J. D. et al. Understanding the origin of visual percepts elicited by electrical stimulation of the human retina. Graefe’s Arch. Clin. Exp. Ophthalmol. 237, 1007–1013 (1999). pdf
  77. Humayun, M. S. et al. Pattern electrical stimulation of the human retina. Vision Res. 39, 2569–2576 (1999). pdf
  78. Weisz, J. M. et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina 19, 540–545 (1999). pdf
  79. Turano, K. A., Dagnelie, G. & Herdman, S. J. Visual stabilization of posture in persons with central visual field loss. Investig. Ophthalmol. Vis. Sci. 37, 1483–1491 (1996). pdf
  80. Sunness, J. S. et al. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Investig. Ophthalmol. Vis. Sci. 36,1863–1874 (1995). pdf
  81. Turano, K. A., Herdman, S. J. & Dagnelie, G. Visual Stabilization of Posture in Retinitis-Pigmentosa and in Artificially Restricted Visual-Fields. Invest. Ophthalmol. Vis. Sci. 34, 3004–3010 (1993). pdf
  82. Dagnelie, G. & Massof, R. W. Foveal cone involvement in retinitis pigmentosa progression assessed through psychophysical impulse response parameters. Investig. Ophthalmol. Vis. Sci. 34, 243–255 (1993). pdf
  83. Dagnelie, G. Temporal impulse response from flicker sensitivities: practical considerations. J. Opt. Soc. Am. A9, 659–672 (1992). pdf
  84. Dagnelie, G., Spekreijse, H. & van Dijk, B. Topography and homogeneity of monkey V1 studied through subdurally recorded pattern-evoked potentials. Vis. Neurosci. 3, 509–25 (1989). pdf
  85. Massof, R. W. et al. Theoretical interpretation and derivation of flash-on-flash threshold parameters in visual system diseases. Appl. Opt. 27, 1014–24 (1988). pdf
  86. Maier, J., Dagnelie, G., Spekreijse, H. & Van Dijk, B. W. Principal components analysis for source localization of VEPs in man. Vis. Res. 27, 165–177 (1987). pdf
  87. Dagnelie, G., De Vries, M. J., Maier, J. & Spekreijse, H. Pattern reversal stimuli: motion or contrast? Doc. Ophthalmol. 61, 343–349 (1986). pdf
  88. Spekreijse, H., Dagnelie, G., Maier, J. & Regan, D. FLICKER AND MOVEMENT CONSTITUENTS OF THE PATTERN REVERSAL RESPONSE. Vis. Res. 25, (1985). pdf
  89. Heleen Van der Marel, E., Dagnelie, G. & Spekreijse, H. Subdurally recorded pattern and luminance EPs in the alert rhesus monkey. Electroencephalogr. Clin. Neurophysiol. 57, 354–368 (1984). pdf
  90. Van Der Marel, H., Dagnelie, G. & Spekreijse, H. Pattern evoked potentials in awake rhesus monkeys. Investig. Ophthalmol. Vis. Sci.21, 457–466 (1981). pdf